Towards developing an instrument to measure knee and hip osteoarthritis (KHOA) flare, the Outcome Measures in Rheumatology (OMERACT) Flares in OA Working Group first sought to identify and define relevant domains of flare in KHOA. Guided by OMERACT Filter 2.1, candidate domains were identified from data generated in interviews, in English or French, with persons with KHOA and health professionals (HPs) who treat OA. The first and second rounds of an online Delphi process with patients and HPs, including researchers, selected relevant domains. The third round provided agreement on the selected domains and their definitions. At the virtual OMERACT 2020 workshop, the proposed domains and their definitions were discussed in facilitated breakout groups with patients and HPs. Participants then voted, with consensus set at ≥70%. Qualitative interviews characterizing OA flare were completed with 29 persons with KHOA and 16 HPs. Content was analyzed and grouped into nine clusters. These candidate domains were included in two Delphi rounds, completed by 91 patients and 165 HPs then 50 patients and 116 HPs, per round, respectively. This resulted in selecting five relevant domains. A final Delphi round, completed by 38 patients and 89 HPs, provided agreement on these domains and their definitions. The OMERACT virtual vote included 27 patients and 106 HPs. The domains and their definitions were endorsed with ≥98% agreement. Domains include Pain, Swelling, Stiffness, Psychological aspects, and Impact of symptoms, all defined "during flare". Using OMERACT methodology, we have developed five domains of KHOA flare that were highly endorsed by patients and HPs. Using OMERACT methodology, we have developed five domains of KHOA flare that were highly endorsed by patients and HPs.In recent years, Shandong Province became one of China's largest carbon emitters; however, existing studies failed to capture the recent trends and the key driving factors behind it at the city level. In this study, we computed the city-level CO2 emission by employing accounting methods and Logarithmic Mean Divisia Index (LMDI) to provide a holistic picture and measure the contributing factors CO2 emissions across 16 cities in Shandong Province during 2010-2018. Research outcomes indicate that Shandong's CO2 emissions showed an increasing trend during 2010-2018, except in 2013. Shandong Province's GDP per capita and population size promote energy-related CO2 emissions from 2010 to 2018. Energy intensity is the main driving force behind Shandong's significant CO2 emission growth, followed by the energy consumption structure. Emission intensity and regional structure partly offset the CO2 emission increase. Industrial structure is the most important driving factor in reducing emissions; however, its emission reduction effect is not stable in some cities and sectors, especially for the nonmetal and metal industry, petroleum and chemical industry, and energy sector. Dongying is the top emitter across Shandong from 2010 to 2018. Its emissions mainly come from the petroleum and chemical industry. The largest driving factors are the energy intensity and industrial structure. Investigating CO2 emissions at the city level yields a strong recommendation that Shandong Province's regions cooperate to improve development patterns. The purpose of this laboratory study is to evaluate the application of a pre-sintered surface augmentation to zirconia (Zir) and lithium disilicate (LDS) ceramics on the delamination strength of adhesive resin cement. The applied surface augmentation was the ruling of lines to the pre-sintered surface of the ceramics. Ninety milled Zir and sixty pressed LDS specimens (3mm×0.5mm×25mm) were created and divided into five groups (n=30). Group 1 Zir no surface treatment (control Zir-NT); Group 2 Zir airborne particle abraded (Zir-APA) with 30μm CoJet; Group 3 Zir pre-sintered surface augmentation (Zir-SA); Group 4 LDS etched (control LDS-etched) and; Group 5 LDS with pre-sintered surface augmentation and etching (LDS-SA). A resin adhesive cement (3mm×1mm×8mm) was then applied and cured to the ceramic specimens. The delamination strength values of the resin cement from the ceramic were recorded. The delamination strength data were analysed statistically using one-way ANOVA and Turkey post hoc analysis. The mean delamination strength and standard deviation, when comparing only the Zir-SA to the resin cement were statistically different (p<0.001); Zir-SA 63.42±11.85, Zir-NT 26.82±12.07, and Zir-APA 48.11±17.85MPa. Comparison between LDS groups were not significantly different (p=0.193); LDS-etched 33.49±16.07 and LDS-SA 28.83±10.15MPa. The delaminated Weibull modulus was highest for surface augmentation Zir specimens (m=13.56) but decreasing to less than half for Zir-APA (m=6.27) and Zir-NT (m=5.68). The Weibull values for the LDS-SA and LDS-etched specimens was 5.63 and 3.38 respectively. Incorporating the pre-sintered surface augmentation to zirconia improved the delamination strength and reliability of Zir to the resin cement but not for LDS. Incorporating the pre-sintered surface augmentation to zirconia improved the delamination strength and reliability of Zir to the resin cement but not for LDS.Vesicular glutamate transporters (VGLUTs) were long thought to be specific markers of glutamatergic excitatory transmission. The discovery, two decades ago, of the atypical VGLUT3 has thoroughly modified this oversimplified view. https://www.selleckchem.com/products/Furosemide(Lasix).html VGLUT3 is strategically expressed in discrete populations of glutamatergic, cholinergic, serotonergic, and even GABAergic neurons. Recent reports show the subtle, but critical, implications of VGLUT3-dependent glutamate co-transmission and its roles in the regulation of diverse brain functions and dysfunctions. Progress in the neuropharmacology of VGLUT3 could lead to decisive breakthroughs in the treatment of Parkinson's disease (PD), addiction, eating disorders, anxiety, presbycusis, or pain. This review summarizes recent findings on VGLUT3 and its vesicular underpinnings as well as on possible ways to target this atypical transporter for future therapeutic strategies.